Exelixis, Inc. v. Intas Pharmaceuticals Ltd.
A $2B+ question in plain sight: what happens when a blockbuster patent fight turns into a who has the right to sell showdown?
Patent litigation isnt just a legal headline anymoreits a strategic market event. And the latest Exelixis v. Intas Pharmaceuti…
